Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. [electronic resource] by
- Balena, R
- Toolan, B C
- Shea, M
- Markatos, A
- Myers, E R
- Lee, S C
- Opas, E E
- Seedor, J G
- Klein, H
- Frankenfield, D
Producer: 19940112
In:
The Journal of clinical investigation vol. 92
Availability: No items available.
|
|
|
19.
|
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. [electronic resource] by
- Schmidt, A
- Rutledge, S J
- Endo, N
- Opas, E E
- Tanaka, H
- Wesolowski, G
- Leu, C T
- Huang, Z
- Ramachandaran, C
- Rodan, S B
- Rodan, G A
Producer: 19960524
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 93
Availability: No items available.
|
|
|
20.
|
Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5- benzofuranol, a potent topical antiinflammatory agent. [electronic resource] by
- Hammond, M L
- Zambias, R A
- Chang, M N
- Jensen, N P
- McDonald, J
- Thompson, K
- Boulton, D A
- Kopka, I E
- Hand, K M
- Opas, E E
Producer: 19900406
In:
Journal of medicinal chemistry vol. 33
Availability: No items available.
|